RNA · Atrium Therapeutics, Inc. · Fails to Deliver
$7.50
-0.46 (-5.78%)
At close · Nov 12
Return incl. dividend (before tax)
Market Cap
$128.29M
Shares
21.57M
Volume · Nov 12
294.72K
Avg daily vol (3M)
288.66K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-18 | 706 | $9.56 | $6,749 |
| 2026-09-15 | 1,196 | $10.21 | $12,211 |
| 2026-09-10 | 48 | $10.51 | $504 |
| 2026-09-08 | 749 | $14.19 | $10,628 |
| 2026-09-04 | 603 | $14.60 | $8,804 |
| 2026-09-03 | 651 | $14.06 | $9,153 |
| 2026-08-21 | 3,946 | $13.48 | $53,192 |
| 2026-08-17 | 183 | $12.84 | $2,350 |
Showing 1–8 of 8 settlements
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
61 filings
61 filers
Visit website
Investor relations